BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8523970)

  • 1. [Susceptibility of bacteria isolated from clinical material to ciprofloxacin].
    Namysł E; Galiński J; Szponar M; Piechowicz L
    Med Dosw Mikrobiol; 1995; 47(1-2):5-9. PubMed ID: 8523970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Susceptibility of methicillin-sensitive and methicillin-resistant staphylococci to ciprofloxacin].
    Namysł E; Piechowicz L; Krzywińska E; Galiński J
    Med Dosw Mikrobiol; 1993; 45(2):149-52. PubMed ID: 8309287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The study of drug resistance in aerobic and anaerobic bacterial flora to selected antibacterial drugs].
    Michalska W; Chylak J; Pietkiewicz K
    Med Dosw Mikrobiol; 1996; 48(1-2):61-70. PubMed ID: 8926770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of anaerobic and aerobic bacteria isolated from patients with mixed infections in Nicaragua.
    Cáceres M; Carrera E; Palma A; Berrios G; Weintraub A; Nord CE
    Rev Esp Quimioter; 1999 Dec; 12(4):332-9. PubMed ID: 10855012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative in vitro activity of ciprofloxacin against aerobic and anaerobic bacteria from clinical isolates.
    Klietmann W; Focht J; Nösner K
    Arzneimittelforschung; 1987 Jun; 37(6):661-6. PubMed ID: 2822054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
    Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview.
    Kayser FH; Novak J
    Am J Med; 1987 Apr; 82(4A):33-9. PubMed ID: 3555058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Specificity of the anaerobic bacterial infections in the surgical and orthopedic wards].
    Kierzkowska M; Majewska A; Sawicka-Grzelak A; Młynarczyk A; Ładomirska-Pestkowska K; Młynarczyk G
    Med Dosw Mikrobiol; 2012; 64(1):29-34. PubMed ID: 22808727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibilities of bovine summer mastitis bacteria to antimicrobial agents.
    Jousimies-Somer H; Pyörälä S; Kanervo A
    Antimicrob Agents Chemother; 1996 Jan; 40(1):157-60. PubMed ID: 8787898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
    Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
    Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-61827 (A-60969), a new fluoronaphthyridine with activity against both aerobic and anaerobic bacteria.
    Fernandes PB; Chu DT; Swanson RN; Ramer NR; Hanson CW; Bower RR; Stamm JM; Hardy DJ
    Antimicrob Agents Chemother; 1988 Jan; 32(1):27-32. PubMed ID: 3348609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
    [No Abstract]   [Full Text] [Related]  

  • 13. Aerobic bacteria isolated from blood cultures of patients and their antibiotic susceptibilities in Harare, Zimbabwe.
    Obi CL; Mazarura E
    Cent Afr J Med; 1996 Dec; 42(12):332-6. PubMed ID: 9164012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aerobic and anaerobic bacterial flora in chronic sinusitis in adults].
    Radosz-Komoniewska H; Kapp-Burzyńska Z; Kłaptocz B; Wilk I; Ekiel A
    Med Dosw Mikrobiol; 1997; 49(1-2):89-94. PubMed ID: 9411078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaerobic and aerobic microflora of pouch of Douglas aspirate v/s high vaginal swab in cases of pelvic inflammatory disease.
    Chaudhry R; Thakur R; Talwar V; Aggarwal N
    Indian J Pathol Microbiol; 1996 Apr; 39(2):115-20. PubMed ID: 9401239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents.
    Citron DM; Goldstein EJ; Merriam CV; Lipsky BA; Abramson MA
    J Clin Microbiol; 2007 Sep; 45(9):2819-28. PubMed ID: 17609322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility of clinical isolates of aerobic gram-positive cocci and anaerobic bacteria in 2008].
    Yoshida I; Yamaguchi T; Kudo R; Fuji R; Takahashi C; Oota R; Kaku M; Kunishima H; Okada M; Horikawa Y; Shiotani J; Kino H; Ono Y; Fujita S; Matsuo S; Kono H; Asari S; Toyokawa M; Kusano N; Nose M; Horii T; Tanimoto A; Miyamoto H; Saikawa T; Hiramatsu K; Kohno S; Yanagihara K; Yamane N; Nakasone I; Maki H; Yamano Y
    Jpn J Antibiot; 2012 Feb; 65(1):49-72. PubMed ID: 22808693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia.
    Gebre-Sealsssie S
    Ethiop Med J; 2007 Oct; 45(4):363-70. PubMed ID: 18326346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activity of metal compounds against aerobic and anaerobic bacteria.
    Chin N; Neu HC
    Diagn Microbiol Infect Dis; 1992 Aug; 15(6):549-52. PubMed ID: 1424509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anaerobic bacteria in bronchoalveolar lavage fluid (BAL) after thoracic surgery].
    Zajac-Lenczewska I; Kedzia A; Skokowski J; Sternau A
    Med Dosw Mikrobiol; 2003; 55(2):173-80. PubMed ID: 14577197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.